Home Applications 217639 Application 217639
Type NDA
Sponsor STEMLINE THERAPEUTICS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ORSERDU ELACESTRANT TABLET;ORAL 345MG No No 002 ORSERDU ELACESTRANT TABLET;ORAL 86MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217639-001 ORSERDU ELACESTRANT HYDROCHLORIDE EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 N217639-002 ORSERDU ELACESTRANT HYDROCHLORIDE EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217639-001 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 N217639-001 10071066 2034-10-10 U-3524 2023-02-24 N217639-001 11779552 2034-10-10 U-3524 2023-11-06 N217639-001 10420734 2036-10-03 U-3524 2023-03-10 N217639-001 11819480 2037-02-28 U-3523 2023-12-21 N217639-001 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 N217639-001 10745343 2038-01-05 U-3523 2023-02-24 N217639-002 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 N217639-002 10071066 2034-10-10 U-3524 2023-02-24 N217639-002 11779552 2034-10-10 U-3524 2023-11-06 N217639-002 10420734 2036-10-03 U-3524 2023-03-10 N217639-002 11819480 2037-02-28 U-3523 2023-12-21 N217639-002 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 N217639-002 10745343 2038-01-05 U-3523 2023-02-24
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217639-001 NCE 2028-01-27 N217639-002 NCE 2028-01-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 46 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N217639-001 ORSERDU EQ 86MG BASE TABLET / ORAL RLD 2023-01-27 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N217639-002 ORSERDU EQ 345MG BASE TABLET / ORAL RLD, RS 2023-01-27 a67488948f0b…
Observed Orange Book patent history# Patent history page 1 of 9 · 344 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217639-001 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 10071066 2034-10-10 U-3524 2023-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 11779552 2034-10-10 U-3524 2023-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 10420734 2036-10-03 U-3524 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 11819480 2037-02-28 U-3523 2023-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-001 10745343 2038-01-05 U-3523 2023-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 10071066 2034-10-10 U-3524 2023-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 11779552 2034-10-10 U-3524 2023-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 10420734 2036-10-03 U-3524 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 11819480 2037-02-28 U-3523 2023-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217639-002 10745343 2038-01-05 U-3523 2023-02-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 8399520 2025-12-25 U-3523 Drug substance, Drug product 2023-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 10071066 2034-10-10 U-3524 2023-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 11779552 2034-10-10 U-3524 2023-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 10420734 2036-10-03 U-3524 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 11819480 2037-02-28 U-3523 2023-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-001 10745343 2038-01-05 U-3523 2023-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 8399520 2025-12-25 U-3523 Drug substance, Drug product 2023-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 10071066 2034-10-10 U-3524 2023-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 11779552 2034-10-10 U-3524 2023-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 10420734 2036-10-03 U-3524 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 11819480 2037-02-28 U-3523 2023-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217639-002 10745343 2038-01-05 U-3523 2023-02-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217639-001 8399520 2025-12-25 U-3523 Drug substance, Drug product 2023-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 10071066 2034-10-10 U-3524 2023-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 10420734 2034-10-10 U-3524 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 11779552 2034-10-10 U-3524 2023-11-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 11819480 2037-02-28 U-3523 2023-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 10385008 2038-01-05 Drug substance, Drug product 2023-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-001 10745343 2038-01-05 U-3523 2023-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-002 8399520 2025-12-25 U-3523 Drug substance, Drug product 2023-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217639-002 7612114 2026-08-18 U-3523 Drug substance, Drug product 2023-03-10 6a471c1ec25d…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 46 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ORSERDU ELACESTRANT Stemline Therapeutics, Inc. aa66ae5c-2bd2-4444-8178-b55651e054ef 2026-06-24 Warnings, Adverse reactions Exact identifier application applno (NDA): 217639 application number: NDA217639
Documents# Document, Submission type, Date table Document Submission type Date 85110 ORIG 2026-02-24 76609 SUPPL 2026-02-24 76565 SUPPL 2023-11-14 73639 ORIG 2023-03-01 73328 ORIG 2023-01-30 73305 ORIG 2023-01-30